Cancer Research and Treatment

Cancer Research and Treatment Search

> Browse Articles > Search

The Use of CD44 Variant 9 and Ki-67 Combination Can Predicts Prognosis Better Than Their Single Use in Early Gastric Cancer

Se-Il Go, Gyung Hyuck Ko, Won Sup Lee, Jeong-Hee Lee, Sang-Ho Jeong, Young-Joon Lee, Soon Chan Hong, Woo Song Ha

Cancer Res Treat. 2019;51(4):1411-1419. Published online February 25, 2019 DOI: https://doi.org/10.4143/crt.2018.663

Web of Science 12 Crossref 10

CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer

Se-Il Go, Gyung Hyuck Ko, Won Sup Lee, Rock Bum Kim, Jeong-Hee Lee, Sang-Ho Jeong, Young-Joon Lee, Soon Chan Hong, Woo Song Ha

Cancer Res Treat. 2016;48(1):142-152. Published online March 17, 2015 DOI: https://doi.org/10.4143/crt.2014.227

Web of Science 37 Crossref 33

A Phase II Trial of Haptaplatin/5-FU and Leucovorin for Advanced Stomach Cancer

Won Sup Lee, Gyeong-Won Lee, Hwal Woong Kim, Ok-Jae Lee, Young-Joon Lee, Gyung Hyuck Ko, Jong-Seok Lee, Joung Soon Jang, Woo Song Ha

Cancer Res Treat. 2005;37(4):208-211. Published online August 31, 2005 DOI: https://doi.org/10.4143/crt.2005.37.4.208

Crossref 5

Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410 FAX: +82-2-792-1410 E-mail: journal@cancer.or.kr

About | Browse Articles | Current Issue | For Authors and Reviewers